[go: up one dir, main page]

NO20022980D0 - Medisinsk og diagnostisk anvendelse av en spesifikk koaktivator for humane nukle¶re reseptorer - Google Patents

Medisinsk og diagnostisk anvendelse av en spesifikk koaktivator for humane nukle¶re reseptorer

Info

Publication number
NO20022980D0
NO20022980D0 NO20022980A NO20022980A NO20022980D0 NO 20022980 D0 NO20022980 D0 NO 20022980D0 NO 20022980 A NO20022980 A NO 20022980A NO 20022980 A NO20022980 A NO 20022980A NO 20022980 D0 NO20022980 D0 NO 20022980D0
Authority
NO
Norway
Prior art keywords
activator
medical
specific
nuclear receptors
diagnostic use
Prior art date
Application number
NO20022980A
Other languages
English (en)
Other versions
NO20022980L (no
Inventor
Maik Obendorf
Siegmund Wolf
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20022980D0 publication Critical patent/NO20022980D0/no
Publication of NO20022980L publication Critical patent/NO20022980L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20022980A 2000-11-03 2002-06-20 Medisinsk og diagnostisk anvendelse av en spesifikk koaktivator for humane nukle¶re reseptorer NO20022980L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054639A DE10054639B4 (de) 2000-11-03 2000-11-03 Verwendung von RanBPM als Co-Modulator von Steroidhormonrezeptoren
PCT/EP2001/012668 WO2002036621A1 (de) 2000-11-03 2001-11-01 Medizinische und diagnostische verwendung eines spezifischen co-aktivators fürs humane nukleäre rezeptoren

Publications (2)

Publication Number Publication Date
NO20022980D0 true NO20022980D0 (no) 2002-06-20
NO20022980L NO20022980L (no) 2002-06-20

Family

ID=7662101

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022980A NO20022980L (no) 2000-11-03 2002-06-20 Medisinsk og diagnostisk anvendelse av en spesifikk koaktivator for humane nukle¶re reseptorer

Country Status (8)

Country Link
US (1) US20030054334A1 (no)
EP (1) EP1330474B1 (no)
JP (1) JP3593529B2 (no)
AT (1) ATE386940T1 (no)
AU (1) AU2002229527A1 (no)
DE (2) DE10054639B4 (no)
NO (1) NO20022980L (no)
WO (1) WO2002036621A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE343795T1 (de) 2003-03-04 2006-11-15 Schering Ag Verfahren zur bestimmung des hormonellen effekts von substanzen mittels der interaktion zwischen dem androgenrezeptor und ewing sarkoma protein.
WO2005035780A1 (ja) * 2003-10-14 2005-04-21 Cellfree Sciences Co.,Ltd. 指標物質の新規スクリーニング方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US851444A (en) * 1905-11-13 1907-04-23 Agfa Ag Amido-oxy-sulfonic acid of phenylnaphthimidazol and process of making same.
US4435417A (en) * 1981-02-20 1984-03-06 Gruppo Lepetit S.P.A. Antiinflammatory 3H-naphtho[1,2-d]imidazoles
ES8503669A1 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
US4880788A (en) * 1987-10-30 1989-11-14 Baylor College Of Medicine Method for preventing and treating thrombosis
US5428546A (en) * 1992-10-16 1995-06-27 Mobile Information Systems Method and apparatus for tracking vehicle location
AU4586697A (en) * 1996-09-20 1998-04-14 Board Of Regents, The University Of Texas System Compositions and methods comprising bard1 and other brca1 binding proteins
US6479256B1 (en) * 1998-03-04 2002-11-12 Icos Corporation Lectomedin materials and methods
AU5901199A (en) * 1998-08-26 2000-03-21 Trustees Of Boston University Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
US6214813B1 (en) * 2000-04-07 2001-04-10 Kinetek Pharmaceuticals, Inc. Pyrazole compounds

Also Published As

Publication number Publication date
US20030054334A1 (en) 2003-03-20
DE10054639A1 (de) 2002-05-16
ATE386940T1 (de) 2008-03-15
WO2002036621A1 (de) 2002-05-10
WO2002036621A8 (de) 2002-07-11
EP1330474B1 (de) 2008-02-20
DE10054639B4 (de) 2004-05-06
EP1330474A1 (de) 2003-07-30
JP3593529B2 (ja) 2004-11-24
DE50113640D1 (de) 2008-04-03
AU2002229527A1 (en) 2002-05-15
JP2004513334A (ja) 2004-04-30
NO20022980L (no) 2002-06-20

Similar Documents

Publication Publication Date Title
DE60320860D1 (de) Super-elastische Titanlegierung für medizinische Verwendung
ATE394121T1 (de) Verwendung von antikörpern gegen das muc18- antigen
CR20200394A (es) Métodos terapéuticos y diagnósticos para enfermedades inflrmatorias mediadas por mostocitos
GB0222495D0 (en) Compounds
EP1238985A4 (en) HUMAN ANTIBODY FOR TRANSPLANTATION OF A REGION OF DETERMINATION OF COMPLEMENTARITY AGAINST GANGLIOSIDE GD3, AND DERIVATIVES THEREOF
DK0753015T3 (da) Monoklonale antistoffer mod Tie-receptoren og anvendelse deraf
Hassel et al. Oral health-related quality of life and depression/anxiety in long-term recurrence-free patients after treatment for advanced oral squamous cell cancer
CY1120175T1 (el) Ανταγωνιστες υποδοχεα clever-1 για αποκλεισμο των ανοσο-ανασταλτικων μακροφαγων τυπου 2
UY27003A1 (es) Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
TW200611695A (en) Pyrrolopyridine derivatives
EP1313753A4 (en) REGULATORY GENE AND SYSTEM FOR USE IN THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS
NO20022980D0 (no) Medisinsk og diagnostisk anvendelse av en spesifikk koaktivator for humane nukle¶re reseptorer
Lin et al. A population-based five-year study on the risk of stroke in patients with osteoporosis in Taiwan
EA200501711A1 (ru) Семейство секретируемых белков
Dierckman et al. In vivo measurement of rotator cuff tear tension: medial versus lateral footprint position
Barrios et al. Letter from Barrios and Escobar regarding article,“trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010”
NO962248D0 (no) Joderte bifenylderivater og deres diagnostiske anvendelse
AR046219A1 (es) Uso de moduladores selectivos de receptores opiaceos en el tratamiento de neuropatias
WO2006113723A3 (en) Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease
John et al. Oral health–related quality of life in patients treated with fixed, removable, and complete dentures 1 month and 6 to 12 months after treatment
Siegel et al. Fatal injury to the external iliac vein by a guide wire during use of a dynamic hip screw (DHS)
ATE422896T1 (de) Eg-vegf/prokineticin 2 rezeptor antagonisten
ATE471724T1 (de) Radioaktiv markierte verbindungen auf peptidbasis und ihre verwendung
FRAX–TEN YEARS World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Plenary Lectures Abstracts
DE60326267D1 (de) Natriumkanal-alpha-untereinheitsvarianten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application